@article{boisteau:hal-03632563,
TITLE = {SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer},
AUTHOR = {Boisteau, Emeric and Fran{\c c}ois, Eric and Aparicio, Thomas and Le Malicot, Karine and Boulahssass, Rabia and Lecomte, Thierry and Laurent-Puig, Pierre and Guiu, Boris and Paillaud, Elena and Galais, Marie-Pierre and Lopez-Trabada Ataz, Daniel and Tougeron, David and Dourthe, Louis-Marie and Guimbaud, Rosine and Samalin, Emmanuelle and Moreau, Marie and Louvet, Christophe and Lepage, C{\^o}me and Li{\`e}vre, Astrid},
URL = {https://hal.science/hal-03632563},
JOURNAL = {Digestive and Liver Disease},
PUBLISHER = {Elsevier},
VOLUME = {54},
NUMBER = {6},
PAGES = {747-754},
YEAR = {2022},
MONTH = Mar, DOI = {10.1016/j.dld.2022.03.001},
KEYWORDS = {Advanced gastric cancer ; Geriatric ; Paclitaxel ; Quality of life ; Ramucirumab},
HAL_ID = {hal-03632563},
HAL_VERSION = {v1},
}